Lanjutan Tarikh Penguatkuasaan untuk Memenuhi Keperluan Kajian Bioekuivalens (BE) bagi Produk Generik dalam Bentuk Dos Oral Tablet/Kapsul yang Bersifat Effervescent, Dispersible, Orodispersible, Sublingual, Buccal dan Chewable

User Rating: 1 / 5

Star ActiveStar InactiveStar InactiveStar InactiveStar Inactive

Download/view the full document.



Go to Circular/Directive for other circulars or directives.

National Pharmaceutical Regulatory Agency (NPRA)
Lot 36, Jalan Universiti, 46200 Petaling Jaya, Selangor, Malaysia.
  • Email:
  • Phone: +603-7883 5400
  • Fax: +603-7956 2924, +603-7956 7075


The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

Site Last Modified

  • Last Modified: Tuesday 27 October 2020, 11:22:44.
© Copyright 2019 . All Rights Reserved National Pharmaceutical Regulatory Agency NPRA

Main Menu English

Choose Your Language